Parathyroid cancer is one of the rarest endocrine malignancies, yet when it occurs, it can lead to serious and life-threatening metabolic complications. Unlike many cancers that primarily cause problems due to tumor growth alone, parathyroid carcinoma significantly affects the entire body through uncontrolled secretion of parathyroid hormone (PTH), leading to severe hypercalcemia (high blood calcium levels).
Effective treatment requires not only oncologic expertise but also a deep understanding of endocrine physiology and complex neck anatomy. Dr. Lovedeep Singh Chauhan, Consultant Surgical Oncologist at Max Super Speciality Hospital, Mohali, provides comprehensive and evidence-based management for patients diagnosed with parathyroid cancer and other endocrine malignancies.
This page offers detailed information about parathyroid cancer—its causes, symptoms, diagnosis, treatment, prognosis, and surgical options—while outlining the advanced care approach available under Dr. Chauhan’s expertise.
The human body typically has four small parathyroid glands located behind the thyroid gland in the neck. These glands are responsible for regulating calcium levels in the bloodstream through the production of parathyroid hormone (PTH).
When parathyroid glands function normally, they maintain precise calcium balance. However, in parathyroid cancer, the malignant gland produces excessive PTH, leading to dangerously elevated calcium levels.
Parathyroid cancer, also known as parathyroid carcinoma, is a rare malignant tumor arising from one of the parathyroid glands. It accounts for less than 1% of cases of primary hyperparathyroidism.
The condition requires early recognition and definitive surgical management for optimal outcomes.
The exact cause of parathyroid cancer remains unclear, but certain genetic and clinical factors are associated with increased risk.
Some patients may have inherited conditions such as:
These genetic abnormalities can predispose individuals to parathyroid carcinoma.
Most cases occur without a clear hereditary cause.
Long-standing untreated hyperparathyroidism may also contribute to increased risk.
The majority of symptoms arise from severe hypercalcemia rather than the tumor mass itself.
Patients may initially experience:
As calcium levels rise further, symptoms may include:
Accurate diagnosis is critical because incomplete surgery significantly increases the risk of recurrence.
The first step usually involves blood tests showing:
Calcium levels in parathyroid cancer are often higher than those seen in benign adenomas.
Imaging helps localize the tumor and assess local invasion. Common investigations include:
Definitive diagnosis is usually established after surgical removal of the tumor. Pathologists look for features such as:
Fine needle aspiration (FNAC) is generally avoided due to the risk of tumor seeding.
Because parathyroid cancer is rare, staging systems are less standardized compared to other cancers. However, evaluation typically focuses on:
Early-stage disease confined to the gland has the best prognosis when completely removed.
Surgery remains the cornerstone of treatment and offers the best chance of cure.
Surgery is the only potentially curative treatment for parathyroid carcinoma.
The recommended approach is en bloc resection, meaning removal of:
Complete removal during the first surgery significantly improves long-term survival, while incomplete excision increases recurrence rates dramatically.
Before surgery, patients often require stabilization of calcium levels.
Treatment may include:
Post-operatively, calcium levels must be closely monitored because sudden drops may occur (hungry bone syndrome).
Parathyroid cancer is generally resistant to conventional chemotherapy.
Radiotherapy may be considered in selected cases. Targeted therapies are currently under research and are not yet part of standard treatment.
Parathyroid carcinoma has a relatively high risk of recurrence, sometimes years after initial surgery.
Early detection of recurrence allows timely intervention.
The anatomy of the neck is complex and contains critical structures requiring high surgical precision.
Dr. Lovedeep Singh Chauhan has extensive experience in endocrine malignancies including thyroid and parathyroid cancers, with training from leading oncology institutes ensuring evidence-based care.
His approach focuses on accurate diagnosis, individualized surgical planning, complete oncologic resection, postoperative metabolic stabilization, and lifelong surveillance.
A structured and carefully monitored approach ensures safe and effective treatment outcomes.
A detailed review of symptoms, previous reports, and biochemical values is performed. Imaging studies are evaluated to determine disease extent.
If calcium levels are significantly elevated, stabilization is done before surgery to reduce perioperative risks.
Surgery is performed under general anesthesia. En bloc resection may be done depending on disease extent to ensure complete removal.
Most patients gradually return to normal activities under medical guidance.
Prognosis depends on multiple clinical and surgical factors that influence long-term outcomes.
Patients who undergo complete en bloc resection during the first surgery generally have significantly better long-term outcomes.
Early consultation with a specialist can significantly improve outcomes and reduce complications.
Early referral improves surgical success and reduces complications.